Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Takeda
Biotech
Neurocrine-Takeda antidepressant hits main mark in phase 2 trial
Neurocrine has nabbed a phase 2 trial win after its oral drug reduced depression severity among adults who haven’t benefited from prior therapies.
Gabrielle Masson
Apr 23, 2024 10:44am
Takeda inks sweet $1.2B-plus immuno-oncology deal with Kumquat
Apr 16, 2024 11:34am
'The Top Line': Inclusivity in psoriasis trials with Takeda
Mar 15, 2024 7:00am
Amid pivot, Denali Therapeutics sends staff packing
Feb 26, 2024 12:22pm
Takeda welcomes new oncology chief from CRISPR—Chutes & Ladders
Feb 9, 2024 9:30am
Phase 2b narcolepsy win powers Takeda toward pivotal trials
Feb 9, 2024 6:02am